T W Kim

A randomised phase II study of modified FOLFIRI.3 vs modified FOLFOX as second-line therapy in patients with gemcitabine-refractory advanced pancreatic cancer

Changhoon Yoo, Jenn-Jiang Hwang, Je Hyeong Kim et al. · British Journal of Cancer · 2009 · 170 citations · Full text

Medicine, Oncology, Pharmacotherapy +12

Phase II study of everolimus with biomarker exploration in patients with advanced gastric cancer refractory to chemotherapy including fluoropyrimidine and platinum

Dok Hyun Yoon, M.-H. Ryu, Y S Park et al. · British Journal of Cancer · 2012 · 87 citations · Full text

Medicine, Oncology, Pharmacology +17

A phase II study of paclitaxel and capecitabine as a first-line combination chemotherapy for advanced gastric cancer

H. Kang, Heung-Moon Chang, T W Kim et al. · British Journal of Cancer · 2008 · 35 citations · Full text

Medicine, Oncology, Pharmacology +17

Nomogram to predict ypN status after chemoradiation in patients with locally advanced rectal cancer

Eun‐Kyoung Jwa, J H Kim, T W Kim et al. · British Journal of Cancer · 2014 · 33 citations · Full text

Medicine, Oncology, Surgery +16

Low prevalence of activated protein C resistance and coagulation factor V Arg506 to Gln mutation among Korean patients with deep vein thrombosis

T W Kim, W K Kim, Je‐Hwan Lee et al. · Journal of Korean Medical Science · 1998 · 25 citations · Full text

Medicine, Genetics, Hematology +17